Besides, BCL2A1 is overexpressed in various neoplastic cells, including hematological malignancies [25,26,27,28,29] and solid tumors [30,31,32], and is known to contribute to tumor progression [33,34,35]. This evidence concerns the gene BCL2A1 and neoplasm.